Latest filing published 02 Mar 2023 for Abbott Laboratories.
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Alejandro D. Wellisch: trading record in brief
Alejandro D. Wellisch (senior executive) discloses dealings in Abbott Laboratories to SEC (Form 4). We count 22 filings; the first trade dates from 22 November 2017 and the latest from 28 February 2023.
Sales make up the whole of the open-market record (3 sales, €102k). Other entries cover 19 share grants.
On 2 March 2023 came the latest disclosure, a share grant for €351k in Abbott Laboratories. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Alejandro D. Wellisch
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 10,650 shares0Common shares without par valueSEC:0001415889-23-003925:0
- 11,955 shares0Common shares without par valueSEC:0001415889-22-002204:0
2 of 2 declarations
